ICN- In play 8:16AM ICN Pharm beats (ICN) 8.77: Reports Q1 (Mar) earnings of $0.16 per share, $0.12 better than the Reuters Research consensus of $0.04; revenues fell 14.2% year/year to $158.7 mln vs the $167.0 mln consensus. Consensus consists of two estimates, one at $0.11 and one at a loss of $0.04, so it appears analysts were split on view of ICN's Q1, or the two estimates were made on a different basis. Revenue consensus consists of one estimate only.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.